Advertisement
Advertisement
SUPN
Supernus Pharmaceuticals, Inc.
43.98
USDSponsored
+0.23
+0.51%
Sep 23, 11:15 UTC -4
Open
Supernus Pharmaceuticals, Inc. Financial Snapshot
| Market Cap | 2.56B |
| Beta | 0.56 |
| Earnings Per Share (EPS) | -1.92 |
| Price-to-Book (P/B) Ratio | 2.41 |
| Operating Margin | 14.14% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | 20.87 |
| Return on Equity (ROE) | 11.13% |
| Current Ratio | 2.08% |
| Free Cash Flow | 61.15M |
